Endothelium-Driven Myocardial Growth or Nitric Oxide at the Crossroads
Authors:
- 1 November 2008
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 18 (8) , 299-305
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Endothelium as master regulator of organ development and growthVascular Pharmacology, 2009
- Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent MechanismJournal of Biological Chemistry, 2008
- Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the HeartCirculation, 2008
- Cardiac growth and angiogenesis coordinated by intertissue interactionsJournal of Clinical Investigation, 2007
- Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heartJournal of Clinical Investigation, 2007
- Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in miceJournal of Clinical Investigation, 2007
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failureJournal of Clinical Investigation, 2005
- Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarctionLife Sciences, 2005
- RGS4 Reduces Contractile Dysfunction and Hypertrophic Gene Induction in Gα qOverexpressing MiceJournal of Molecular and Cellular Cardiology, 2001
- RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overloadJournal of Clinical Investigation, 1999